Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Daniel M. Hartung; David M. Cohen; Atul Deodhar; Dennis N. Bourdette

doi:10.7326/L19-0519

Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Daniel M. Hartung, David M. Cohen, Atul Deodhar, Dennis N. Bourdette

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	601-602
Number of pages	2
Journal	Annals of internal medicine
Volume	171
Issue number	8
DOIs	https://doi.org/10.7326/L19-0519
State	Published - Oct 15 2019

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/L19-0519

Cite this

@article{6be4d5a8a32f4bcb9411dff4869c9170,

title = "Older Drugs With Limited Trial Evidence: Are They Worth the Expense?",

author = "Hartung, {Daniel M.} and Cohen, {David M.} and Atul Deodhar and Bourdette, {Dennis N.}",

year = "2019",

month = oct,

day = "15",

doi = "10.7326/L19-0519",

language = "English (US)",

volume = "171",

pages = "601--602",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Older Drugs With Limited Trial Evidence

T2 - Are They Worth the Expense?

AU - Hartung, Daniel M.

AU - Cohen, David M.

AU - Deodhar, Atul

AU - Bourdette, Dennis N.

PY - 2019/10/15

Y1 - 2019/10/15

UR - http://www.scopus.com/inward/record.url?scp=85073182383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073182383&partnerID=8YFLogxK

U2 - 10.7326/L19-0519

DO - 10.7326/L19-0519

M3 - Article

C2 - 31610564

AN - SCOPUS:85073182383

SN - 0003-4819

VL - 171

SP - 601

EP - 602

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 8

ER -

Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this